TFPI (Inhibiteur de la voie du facteur tissulaire)
Pour en savoir plus sur la cible
- Gupta N, Seth T, Aggarwal S, Atri S, Shaikh BA, Nigam RK, Jain A, Baveja A, Digra SK, Vyas B, Sharma V. Revolutionizing Treatment Strategies through Inhibition of Tissue Factor Pathway Inhibitor: A Promising Therapeutic Approach for Hemophilia Management. J Assoc Physicians India. 2025 Apr;73(4):e47-e54. doi: 10.59556/japi.73.0928. PMID: 40200623.
- Ahnström J, Petri A, Crawley JTB. Tissue factor pathway inhibitor - cofactor-dependent regulation of the initiation of coagulation. Curr Opin Hematol. 2024 Nov 1;31(6):315-320. doi: 10.1097/MOH.0000000000000838. Epub 2024 Aug 26. PMID: 39259668; PMCID: PMC11426987.
- Wojtukiewicz MZ, Mysliwiec M, Tokajuk A, Kruszewska J, Politynska B, Jamroze A, Wojtukiewicz AM, Tang DG, Honn KV. Tissue factor pathway inhibitor-2 (TFPI-2)-an underappreciated partaker in cancer and metastasis. Cancer Metastasis Rev. 2024 Dec;43(4):1185-1204. doi: 10.1007/s10555-024-10205-7. Epub 2024 Aug 17. PMID: 39153052; PMCID: PMC11554837.